Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.

[1]  A. Jemal,et al.  Colorectal cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[3]  G. Ciliberto,et al.  An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer , 2022, Cancers.

[4]  Saran Long,et al.  ER-Targeting Cyanine Dye as an NIR Photoinducer to Efficiently Trigger Photoimmunogenic Cancer Cell Death. , 2022, Journal of the American Chemical Society.

[5]  Qiang Yu,et al.  Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer , 2021, Advanced science.

[6]  D. Ron,et al.  Pharmacological targeting of endoplasmic reticulum stress in disease , 2021, Nature reviews. Drug discovery.

[7]  Liming Yang,et al.  IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1+/- mice display increases atherosclerotic plaque stability , 2021, Theranostics.

[8]  Yizheng Tan,et al.  Oxidative Polymerization in Living Cells. , 2021, Journal of the American Chemical Society.

[9]  Shiwen Xu,et al.  Roles of selenoprotein S in reactive oxygen species-dependent neutrophil extracellular trap formation induced by selenium-deficient arteritis , 2021, Redox biology.

[10]  F. Piscaglia,et al.  Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC , 2021, Journal of hepatocellular carcinoma.

[11]  R. Liu,et al.  Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  C. Alexiou,et al.  An Endoplasmic Reticulum Specific Pro‐amplifier of Reactive Oxygen Species in Cancer Cells , 2021, Angewandte Chemie.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  A. M. Muñoz Martín,et al.  Oral drugs in the treatment of metastatic colorectal cancer , 2021, Therapeutic advances in medical oncology.

[15]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[16]  K. Messer,et al.  Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways , 2020, British Journal of Cancer.

[17]  Qi Wang,et al.  Selenoprotein S attenuates endothelial dysfunction in a diabetic vascular chip , 2020, Experimental Gerontology.

[18]  T. Kamura,et al.  Cul5-type Ubiquitin Ligase KLHDC1 Contributes to the Elimination of Truncated SELENOS Produced by Failed UGA/Sec Decoding , 2020, iScience.

[19]  C. Widmann,et al.  CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma , 2019, Oncotarget.

[20]  Xiao-dong Zhu,et al.  Emerging agents and regimens for hepatocellular carcinoma , 2019, Journal of Hematology & Oncology.

[21]  Xiaojie Wang,et al.  Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin‐based chemotherapy resistance of colorectal cancer , 2019, Journal of cellular physiology.

[22]  J. Yun,et al.  AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation , 2019, Oncogene.

[23]  Luyong Zhang,et al.  Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non‐small cell lung cancer cells via Nrf2 inhibition , 2019, British journal of pharmacology.

[24]  J. Staerk,et al.  The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress , 2019, The Journal of Biological Chemistry.

[25]  Jing-Gung Chung,et al.  Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF‐κB‐modulated tumor progression in bladder cancer in vitro and in vivo , 2019, Environmental toxicology.

[26]  Zhen Chen,et al.  miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity , 2018, Cellular Physiology and Biochemistry.

[27]  Shiwen Xu,et al.  Selenoprotein S silencing triggers mouse hepatoma cells apoptosis and necrosis involving in intracellular calcium imbalance and ROS-mPTP-ATP. , 2018, Biochimica et biophysica acta. General subjects.

[28]  E. G. Varlamova.  Participation of selenoproteins localized in the ER in the processes occurring in this organelle and in the regulation of carcinogenesis-associated processes. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[29]  R. Hardison,et al.  Selenoproteins regulate stress erythroid progenitors and spleen microenvironment during stress erythropoiesis. , 2018, Blood.

[30]  Fen Fu,et al.  Selenoprotein S inhibits inflammation-induced vascular smooth muscle cell calcification , 2018, JBIC Journal of Biological Inorganic Chemistry.

[31]  F. Ciardiello,et al.  Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer , 2017, Oncotarget.

[32]  Herman Yeger,et al.  Combination therapy in combating cancer , 2017, Oncotarget.

[33]  Kuen-Feng Chen,et al.  STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma , 2014, Clinical Cancer Research.

[34]  Kuen-Feng Chen,et al.  SHP-1 is a target of regorafenib in colorectal cancer , 2014, Oncotarget.

[35]  A. Rosenthal,et al.  Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer , 2014, International journal of cancer.

[36]  L. Chavatte,et al.  Selective Up-regulation of Human Selenoproteins in Response to Oxidative Stress* , 2014, The Journal of Biological Chemistry.

[37]  L. Ellis,et al.  miR‐203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase , 2014, Molecular oncology.

[38]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[39]  Xiangzong Meng,et al.  MAPK cascades in plant disease resistance signaling. , 2013, Annual review of phytopathology.

[40]  Jiwon Ahn,et al.  Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21Cip1 downregulation are required for shikonin-induced apoptosis , 2013, Apoptosis.

[41]  C. Köhne,et al.  Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  Andrew T Chan,et al.  Statins and colorectal cancer. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  Y. Awasthi,et al.  Gsta4 Null Mouse Embryonic Fibroblasts Exhibit Enhanced Sensitivity to Oxidants: Role of 4-Hydroxynonenal in Oxidant Toxicity. , 2013, Open journal of apoptosis.

[44]  P. Hoff,et al.  Oxaliplatin-related thrombocytopenia. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  K. Hofmann,et al.  The Human Selenoprotein VCP-interacting Membrane Protein (VIMP) Is Non-globular and Harbors a Reductase Function in an Intrinsically Disordered Region* , 2012, The Journal of Biological Chemistry.

[46]  D. Zopf,et al.  Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity , 2011, International journal of cancer.

[47]  Kaixun Huang,et al.  Influence of SelS gene silence on beta-Mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. , 2010, Biochimica et biophysica acta.

[48]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[49]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[50]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[51]  DelindaA . Johnson,et al.  Selenium deficiency activates mouse liver Nrf2-ARE but vitamin E deficiency does not. , 2008, Free Radical Biology & Medicine.

[52]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[53]  A. Scorilas,et al.  Alterations in mRNA Expression of Apoptosis‐Related Genes BCL2, BAX, FAS, Caspase‐3, and the Novel Member BCL2L12 after Treatment of Human Leukemic Cell Line HL60 with the Antineoplastic Agent Etoposide , 2006, Annals of the New York Academy of Sciences.

[54]  X. Lei,et al.  Impacts of glutathione peroxidase-1 knockout on the protection by injected selenium against the pro-oxidant-induced liver aponecrosis and signaling in selenium-deficient mice. , 2003, Free radical biology & medicine.

[55]  R. Falk,et al.  Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. , 2002, Journal of the American Society of Nephrology : JASN.

[56]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.